DOI: 10.12890/2021_002358

Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis

Authors

  • Mickaël Chouk Service de Rhumatologie, CHRU Besançon, Besançon, France
  • Alexandre Halb Service de Neurologie, CHRU Besançon, Besançon, France
  • Christine Mekhail Service de Rhumatologie, CHRU Besançon, Besançon, France
  • Amélie Godot Service de Médecine Interne, CHRU Besançon, Besançon, France
  • Frank Verhoeven Service de Rhumatologie, CHRU Besançon, Besançon, France
  • Clément Prati Service de Rhumatologie, CHRU Besançon, Besançon, France
  • Daniel Wendling Service de Rhumatologie, CHRU Besançon, Besançon, France

mchouk@chu-besancon.fr

Keywords

Rheumatoid arthritis, rheumatoid meningitis, rituximab, leptomeningitis, seizure

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized mainly by arthritis, with the possible occurrence of extra-articular manifestations. We report the case of a patient who developed leptomeningitis as the first sign of RA, one year before the diagnosis of RA. Methylprednisolone 1000 mg was given intravenously. Because of the onset of seizures and cognitive impairment, rituximab was started. After three cycles of rituximab (1000 mg on day 0 and 1000 mg on day 15, every 6 months), neurological clinical examination, MRI and electroencephalogram findings were significantly improved.

View the entire article

Downloads

References

  1. Joaquim AF, Appenzeller S. Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev 2015;14(12):1116–1122.
  2. Rodriguez Alvarez M, Rodríguez Valencia LM, Seidman R, Acharya A, Espina N, Ravindran N, et al. Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases. Clin Rheumatol 2020;39(12):3833–3845.
  3. Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, et al. Rheumatoid meningitis: a case report and review of the literature. Neurol Clin Pract 2020;10(1):73–83.
  4. Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res Clin Rheumatol 2018;32(4):500–510.
  5. Turesson C, Schaid DJ, Weyand CM, Jacobsson LTH, Goronzy JJ, Petersson IF, et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005;7(6):R1386–R1393.

Published

2021-04-21

Issue

Vol. 8 No. 4 (2021)

How to Cite

1.
Chouk M, Halb A, Mekhail C, Godot A, Verhoeven F, Prati C, et al. Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis. EJCRIM [Internet]. 2021 Apr. 21 [cited 2026 Nov. 3];8(4). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2358